Publication|Articles|September 24, 2025
Supplements and Featured Publications
- Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy
Long-Acting Injectable Program Implementation Insights From Genoa Healthcare® Pharmacy
Listen
0:00 / 0:00
Advertisement
This educational resource was sponsored by Johnson & Johnson.
Part 2 of this educational resource provides insights for institutions seeking to implement a pharmacist-led long-acting injectable administration program for schizophrenia.
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Highlighting Gaps in Allergic Rhinitis Care, Allergen Immunotherapy Access
2
Novel CLL Therapies Prompt New Treatment Considerations
3
Anlotinib Plus Chemotherapy Shows Promising Results in Advanced Soft Tissue Sarcoma
4
Congress Unveils Massive Funding Bill to Avert Shutdown
5
